Seven years' experience of Mohs micrographic surgery in a UK centre, and development of a UK minimum dataset and audit standards
Authors:
Open Access
- 21 March 2013
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 38 (3) , 262-269
Abstract
Summary: Background: Mohs micrographic surgery (MMS) is the gold-standard treatment for high-risk basal cell carcinomas and a variety of other cutaneous tumours, including dermatofibromasarcoma protuberans and microcystic adnexal carcinoma. Previous large-scale case series, audits and reviews have allowed evaluation of MMS outcomes, such as BCC recurrence rates. However, to date there has been no systematic UK MMS audit, and certain important aspects of care, such as postoperative functional outcomes, have not yet been subject to scrutiny. Aims: To review audit data from our centre, and from this to develop a minimum dataset and audit standards for UK MMS centres, on behalf of the British Society of Dermatological Surgery (BSDS). Methods: An MMS database was developed locally and modified in response to repeated audit cycles since the introduction of the MMS service. A minimum dataset was developed using this experience. Results: In our department, primary BCC recurrence rates are reassuringly low at 0.3%, at both 2 and 5 years. Histopathological discordance is < 2%, and aesthetic and functional outcomes at 3 months are good. Conclusions: The collation of audit data has been simplified by use of the minimum dataset, which we propose for all UK MMS centres, on behalf of the BSDS.Keywords
This publication has 16 references indexed in Scilit:
- Concordance of Frozen and Permanent Sections for the Diagnosis of Skin LesionsDermatologic Surgery, 2010
- Surgical Excision of Basal Cell Carcinoma with Complete Margin Control: Outcome at 5-Year Follow-UpDermatology, 2010
- Randomized Comparison of Mohs Micrographic Surgery and Surgical Excision for Small Nodular Basal Cell CarcinomaDermatologic Surgery, 2009
- Five-Year Cycle of Basal Cell Carcinoma Management Re-auditOrbit, 2009
- Five-Year Cycle of Basal Cell Carcinoma Management Re-auditOrbit, 2009
- Perineural InvasionDermatologic Surgery, 2009
- Mohs micrographic surgery histopathology concordanceJournal of the American Academy of Dermatology, 2009
- Guidelines for the management of basal cell carcinomaBritish Journal of Dermatology, 2008
- Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-upJournal of the American Academy of Dermatology, 2005
- Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005